"Weight-Loss Drug Zepbound Faces Shortages and Backorders at Rite Aid, Amazon, and Eli Lilly"

TL;DR Summary
Eli Lilly & Co. acknowledges potential difficulties in obtaining its weight loss drug Zepbound due to high demand, with reports of backorders and delays at pharmacies across the US, prompting concerns about shortages.
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
0 min
vs 1 min read
Condensed
38%
53 → 33 words
Want the full story? Read the original article
Read on Bloomberg